Carrie Williams

About the Author Carrie Williams


Oppenheimer Believes Acuity Brands (AYI) Won’t Stop Here

In a report released yesterday, Christopher Glynn from Oppenheimer assigned a Buy rating to Acuity Brands (AYI), with a price target of $205.00.

Roxgold (ROGFF) Gets a Buy Rating from RBC Capital

RBC Capital analyst Wayne Lam maintained a Buy rating on Roxgold (ROGFF) on April 16 and set a price target of C$2.25.

Codiak BioSciences (CDAK) Receives a Buy from William Blair

In a report issued on April 12, Matt Phipps from William Blair reiterated a Buy rating on Codiak BioSciences (CDAK). The company’s shares …

Oppenheimer Keeps a Hold Rating on United Rentals (URI)

Oppenheimer analyst Scott Schneeberger maintained a Hold rating on United Rentals (URI) today. The company’s shares closed last Thursday at $325.

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and Xenon (XENE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vir Biotechnology (VIR) and Xenon …

H.C. Wainwright Sticks to Its Hold Rating for Inovio Pharmaceuticals (INO)

In a report released today, Ram Selvaraju from H.C.

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Arcus Biosciences (RCUS) and Clarmin Explorations (OtherCLXPF)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bausch Health Companies (BHC), Arcus …

Needham Releases a Buy Rating on NeoGenomics (NEO)

In a report released today, Michael Matson from Needham assigned a Buy rating to NeoGenomics (NEO), with a price target of $65.00.

Analysts Offer Insights on Healthcare Companies: and Sarepta Therapeutics (SRPT)

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Sarepta Therapeutics (SRPT) with …

Uranium Energy (UEC) Receives a Rating Update from a Top Analyst

In a report released today, Heiko Ihle from H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts